CheckMyRecalls

Pfizer Inc. recalls DOBUTamine Injection

Published
2 Jul 2025
Units affected
98,410 vials
Agency
FDA
Country
United States

The hazard

Discoloration; discolored solution from cracked vials

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62

Brand / company
Pfizer Inc.
Codes / lots
Lot KA5023, exp 02/28/2026
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 2 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.